1. Revisiting the Cardiotoxic Effect of Chloroquine

   • Marguerite Blignaut
   • Yolandi Espach
   • Barbara Huisamen

   ORIGINAL ARTICLE 11 January 2019 Pages: 1 - 11

   

2. Inhibition of Phosphoglycerate Mutase 5 Reduces Necroptosis in Rat Hearts Following Ischemia/Reperfusion Through Suppression of Dynamin-Related Protein 1

   • Lang She
   • Hua Tu
   • Jun Peng

   ORIGINAL ARTICLE 14 January 2019 Pages: 13 - 23

   

3. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis

   • Hangqi Luo
   • Changzuan Zhou
   • Hangyuan Guo

   ORIGINAL ARTICLE 21 January 2019 Pages: 25 - 33

   

4. Inhibition of Niemann-Pick C1-Like 1 by Ezetimibe Reduces Dietary 5β,6β-Epoxycholesterol Absorption in Rats

   • Bungo Shirouchi
   • Yumiko Furukawa
   • Masao Sato

   ORIGINAL ARTICLE 22 January 2019 Pages: 35 - 44

   

5. Dexmedetomidine Preconditioning Protects Cardiomyocytes Against Hypoxia/Reoxygenation-Induced Necroptosis by Inhibiting HMGB1-Mediated Inflammation

   • Jingyi Chen
   • Zhenzhen Jiang
   • Xianyu Wang

   ORIGINAL ARTICLE 24 January 2019 Pages: 45 - 54

   

6. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents

   • Yong Hoon Kim
   • Ae-Young Her
   • Yangsoo Jang

   ORIGINAL ARTICLE 10 January 2019 Pages: 55 - 67

   

7. Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia

   • Henry N. Ginsberg
   • Jaakko Tuomilehto
   • Frederick J. Raal

   SHORT COMMUNICATION Open access 08 February 2019 Pages: 69 - 76

   

8. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology

   • Krzysztof Ozierański
   • Paweł Balsam
   • Grzegorz Opolski

   ORIGINAL ARTICLE 16 January 2019 Pages: 77 - 86

   

9. Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?

   • Carlos G. Santos-Gallego
   • Alvaro Garcia-Ropero
   • Juan Jose Badimon

   ORIGINAL ARTICLE 24 January 2019 Pages: 87 - 95

   

10. Rationale, Design, and Baseline Characteristics of the Prospective Japan Acute Myocardial Infarction Registry (JAMIR)

    • Satoshi Honda
    • Kensaku Nishihira
    • on behalf of the JAMIR investigators

    ORIGINAL ARTICLE Open access 23 November 2018 Pages: 97 - 103

    

11. Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions

    • Daniel A. Hyman
    • Vincent Siebert
    • Yochai Birnbaum

    REVIEW ARTICLE 25 January 2019 Pages: 105 - 117

12. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases

    • Zhonglin Cai
    • Jianzhong Zhang
    • Hongjun Li

    REVIEW ARTICLE 24 January 2019 Pages: 119 - 128